5Durie BG,Harousseau JL,Miguel JS,et al. International Myeloma Working Group: international uniform response criteria for multiple myeloma. Leukemia, 2006,20 (9) : 1467-1473. 被引量：1
6Chauhan D, Hideshima T,Mitsiades C,et al. Proteasome irihibitor therapy in multiple myeloma. Mol Cancer Ther, 2005,4(4) : 686- 692. 被引量：1
7Pineda-Roman M,Zangari M,van Rhee F,et ah VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia, 2008,22(7) : 1419-1427. 被引量：1
8Chanan-Khan AA, Kaufiuan JL,Mehta J,et al. Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a muhicenter retrospective study. Blood,2007,109(6): 2604-2606. 被引量：1
二级参考文献5
1Gregersen H, Ibsen JS, Nielsen M. Renal insufficiency in myelomatosis. Prognostic factors and survival. Ugeskr Laeger,1997 ,159:3387-3392. 被引量：1
2Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. QJM, 1997,90:773-780. 被引量：1
3Pierre MR. Monoclonal gammopathies: multiple myloma, amyloidosis and related disorders. In: Robert WS, Carl WG, eds. Disease of the kidney. 6th ed. New York : Little, 1996.2130-2145. 被引量：1
4Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore), 1980,59:380-392. 被引量：1
5Blade J, Fernandez-Llama P, Bosch F, et al.Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.Arch Intern Med,1998 ,158:1889-1893. 被引量：1
2Kumar S K,Rajkumar S V, Dispenzieri A,et al. Im- proved survival in multiple myeloma and the impact ofnoveltherapies[J. Blood, 2008,111 (5) : 2516- 2 520. 被引量：1
3Chanan-Khan A A,Kaufman J L,Mehta J,et al. Ac- tivity and safety of bortezomib in multipie myeloma patients with advanced renal failure: a multicenter retrospective study[JJ. Blood,2007,109(6) : 2604- 2 606. 被引量：1
4BarlogieB, Shaughneay J, Tricot G? et al. Effect of Vel-cade combined with Dexamethasone on multiple myeloma[J]. Journal of Central South University ( Medical Sci-ences) ,2010,35(8) :864 - 866. 被引量：1
5KsufmanJ L.Nonka A, Vrena al.Bortezomib, thali-do- mide and dexamethasone induction therapy for pa-tients with symptomatic multiple myelenm [J], Cancer,2010,116(13):3143-3151. 被引量：1
